Literature DB >> 7571178

Subcapsular hematoma due to ESWL: risk factors. A study of 4,247 patients.

A Kostakopoulos1, N J Stavropoulos, C Macrychoritis, C Deliveliotis, K P Antonopoulos, D Picramenos.   

Abstract

A study of 4,247 shockwave lithotripsy treatment was performed to identify and analyze the risk factors for the development of post-extracorporeal shock-wave lithotropsy hematomas. The Dornier HM-3 and HM-4 lithotriptors were used. We recognized 23 hematomas in 23 patients (0.54%). Various factors were examined to identify the certain predisposing risk factors. There was no correlation of sex, age, stone number, stone size, stone location, number of shock waves and voltage used with the occurrence rate of hematoma. We found that patients with pre-existing hypertension and especially those with poor control of it had a significantly increased incidence of perinephric hematoma.

Entities:  

Mesh:

Year:  1995        PMID: 7571178     DOI: 10.1159/000282741

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  Hepatic haematoma after shockwave lithotripsy for renal stones.

Authors:  Chi-Fai Ng; Vincent T T Law; Peter K F Chiu; Chong-Boon Tan; Chi-Wai Man; Peggy S K Chu
Journal:  Urol Res       Date:  2012-07-11

2.  A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.

Authors:  Fabio Nussberger; Beat Roth; Tobias Metzger; Bernhard Kiss; George N Thalmann; Roland Seiler
Journal:  Urolithiasis       Date:  2016-08-30       Impact factor: 3.436

3.  Life-threatening complication after extracorporeal shock wave lithotripsy for a renal stone: a hepatic subcapsular hematoma.

Authors:  Tae-Beom Kim; Ho-Ki Park; Kwang-Yeom Lee; Khae-Hawn Kim; Han Jung; Sang-Jin Yoon
Journal:  Korean J Urol       Date:  2010-03-19

4.  Subcapsular hepatic hematoma with right hepatic vein thrombosis: a complication of shock wave lithotripsy.

Authors:  Jennifer Gordetsky; Sean Hislop; Mark Orloff; Melanie Butler; Erdal Erturk
Journal:  Can Urol Assoc J       Date:  2008-02       Impact factor: 1.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.